J.J. Body

3.9k total citations · 2 hit papers
60 papers, 2.8k citations indexed

About

J.J. Body is a scholar working on Oncology, Orthopedics and Sports Medicine and Molecular Biology. According to data from OpenAlex, J.J. Body has authored 60 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Oncology, 25 papers in Orthopedics and Sports Medicine and 13 papers in Molecular Biology. Recurrent topics in J.J. Body's work include Bone health and treatments (36 papers), Bone health and osteoporosis research (21 papers) and Radiopharmaceutical Chemistry and Applications (11 papers). J.J. Body is often cited by papers focused on Bone health and treatments (36 papers), Bone health and osteoporosis research (21 papers) and Radiopharmaceutical Chemistry and Applications (11 papers). J.J. Body collaborates with scholars based in Belgium, United States and France. J.J. Body's co-authors include Alain Lortholary, Olivia Fromigué, Allan Lipton, R. Bell, F. Yunus, Erhard Quebe‐Fehling, Isabelle Mancini, Glenn Mills, Ehtesham Abdi and Matti Aapro and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

J.J. Body

57 papers receiving 2.7k citations

Hit Papers

Zoledronic Acid Is Superior to Pamidronate in the Treatme... 2001 2026 2009 2017 2001 2017 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Zoledronic Acid Is Superior to Pamidronate in the Treatment of Hypercalcemia of Malignancy: A Pooled Analysis of Two Randomized, Controlled Clinical Trials
    2001 520 citations J.J. Body et al. profile →
  2. Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial
    2017 382 citations David L. Kendler, Fernando Marín et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.J. Body Belgium 25 1.9k 1.3k 683 484 446 60 2.8k
Azeez Farooki United States 24 1.5k 0.8× 1.2k 0.9× 707 1.0× 217 0.4× 594 1.3× 61 2.7k
R.A. Hannon United Kingdom 26 1.9k 1.0× 1.8k 1.4× 931 1.4× 287 0.6× 305 0.7× 55 3.1k
David Hosking United Kingdom 28 2.4k 1.3× 2.4k 1.9× 959 1.4× 150 0.3× 465 1.0× 59 3.7k
Martin Pecherstorfer Austria 29 1.8k 0.9× 703 0.6× 443 0.6× 523 1.1× 284 0.6× 100 2.6k
A.J.P. Yates United Kingdom 26 2.3k 1.2× 2.6k 2.1× 1.1k 1.5× 197 0.4× 461 1.0× 43 3.7k
Michael Maricic United States 22 1.2k 0.6× 1.7k 1.4× 863 1.3× 83 0.2× 445 1.0× 47 2.4k
Ann E. Kearns United States 23 759 0.4× 839 0.7× 831 1.2× 109 0.2× 435 1.0× 55 2.2k
Antonio Lombardi United States 20 3.5k 1.8× 4.0k 3.1× 1.6k 2.4× 202 0.4× 810 1.8× 36 5.1k
Grattan C. Woodson United States 12 1.5k 0.8× 1.7k 1.3× 1.1k 1.6× 107 0.2× 241 0.5× 18 2.4k
Ronald Emkey United States 27 3.2k 1.7× 3.7k 2.9× 1.5k 2.3× 172 0.4× 577 1.3× 45 4.6k

Countries citing papers authored by J.J. Body

Since Specialization
Citations

This map shows the geographic impact of J.J. Body's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.J. Body with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.J. Body more than expected).

Fields of papers citing papers by J.J. Body

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.J. Body. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.J. Body. The network helps show where J.J. Body may publish in the future.

Co-authorship network of co-authors of J.J. Body

This figure shows the co-authorship network connecting the top 25 collaborators of J.J. Body. A scholar is included among the top collaborators of J.J. Body based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.J. Body. J.J. Body is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Charles, Adrian, Michel Moreau, Murielle Surquin, et al.. (2023). The effect of fracture recency on observed 5-year fracture probability: A study based on the FRISBEE cohort. Bone Reports. 18. 101660–101660. 1 indexed citations
2.
Minisola, Salvatore, Fernando Marín, David L. Kendler, et al.. (2019). Serum 25-hydroxy-vitamin D and the risk of fractures in the teriparatide versus risedronate VERO clinical trial. Archives of Osteoporosis. 14(1). 10–10. 5 indexed citations
3.
Body, J.J., Pierre Bergmann, Steven Boonen, et al.. (2012). Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications. Osteoporosis International. 23(S1). 1–23. 59 indexed citations
4.
Hadji, Peyman, Matti Aapro, J.J. Body, et al.. (2011). Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment. Annals of Oncology. 22(12). 2546–2555. 134 indexed citations
5.
Magné, Nicolas, Cyrus Chargari, R.O. Mirimanoff, et al.. (2010). European French-speaking study from the GEMO group on bone metastases management: a special focus on external beam radiotherapy practice survey. Supportive Care in Cancer. 19(10). 1565–1572. 9 indexed citations
6.
Devogelaer, J.-P., Jacques P. Brown, P. Burckhardt, et al.. (2007). Zoledronic acid efficacy and safety over five years in postmenopausal osteoporosis. Osteoporosis International. 18(9). 1211–1218. 51 indexed citations
7.
Body, J.J.. (2006). Tumor bone disease. Annales d Endocrinologie. 67(2). 166–172.
8.
Peretz, Anne, et al.. (2003). Response to alendronate in osteoporotic women previously treated with pamidronate. Maturitas. 44(2). 111–115. 7 indexed citations
9.
Fromigué, Olivia & J.J. Body. (2002). Bisphosphonates influence the proliferation and the maturation of normal human osteoblasts. Journal of Endocrinological Investigation. 25(6). 539–546. 109 indexed citations
10.
Body, J.J.. (2002). MANAGEMENT OF PRIMARY OSTEOPOROSIS. Acta Clinica Belgica. 57(5). 277–283. 16 indexed citations
11.
Body, J.J. & Isabelle Mancini. (2001). Bisphosphonates for cancer patients: why, how, and when?. Supportive Care in Cancer. 10(5). 399–407. 66 indexed citations
12.
Mancini, Isabelle, Dominique Lossignol, & J.J. Body. (2000). Opioid switch to oral methadone in cancer pain. Current Opinion in Oncology. 12(4). 308–313. 40 indexed citations
13.
Body, J.J.. (1999). The syndrome of anorexia-cachexia. Current Opinion in Oncology. 11(4). 255–255. 35 indexed citations
14.
Lacroix, Marc, et al.. (1998). Production and regulation of interleukin-11 by breast cancer cells. Cancer Letters. 127(1-2). 29–35. 42 indexed citations
15.
Lacroix, Marc & J.J. Body. (1997). Regulation of c-fos and c-jun Expression by Calcitonin in Human Breast Cancer Cells. Calcified Tissue International. 60(6). 513–519. 15 indexed citations
16.
Body, J.J.. (1995). Calcitonin for prevention and treatment of postmenopausal osteoporosis. Clinical Rheumatology. 14(S3). 18–21. 3 indexed citations
17.
Body, J.J. & J.C. Dumon. (1994). Treatment of tumour-induced hypercalcaemia with the bisphosphonate pamidronate: Dose-response relationship and influence of tumour type. Annals of Oncology. 5(4). 359–363. 60 indexed citations
18.
19.
Dumon, J.C., et al.. (1992). Nasal human calcitonin for tumor-induced hypercalcemia. Calcified Tissue International. 51(1). 18–19. 17 indexed citations
20.
Body, J.J. & Abraham Borkowski. (1987). Nutrition and quality of life in cancer patients. European Journal of Cancer and Clinical Oncology. 23(2). 127–129. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Azeez Farooki Breakdown of academic impact, for papers by R.A. Hannon Breakdown of academic impact, for papers by David Hosking Breakdown of academic impact, for papers by Martin Pecherstorfer Breakdown of academic impact, for papers by A.J.P. Yates Breakdown of academic impact, for papers by Michael Maricic Breakdown of academic impact, for papers by Ann E. Kearns Breakdown of academic impact, for papers by Antonio Lombardi Breakdown of academic impact, for papers by Grattan C. Woodson Breakdown of academic impact, for papers by Ronald Emkey
Rankless by CCL
2026